The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
In vitro assessments of nanomaterial toxicity
Open accessAbstract
Nanotechnology has grown from a scientific interest to a major industry with both commodity and specialty nanomaterial exposure to global populations and ecosystems. Sub-micron materials are currently used in a wide variety of consumer products and in clinical trials as drug delivery carriers and imaging agents. Due to the expected growth in this field and the increasing public exposure to nanomaterials, both from intentional administration and inadvertent contact, improved characterization and reliable toxicity screening tools are required for new and existing nanomaterials. This review discusses current methodologies used to assess nanomaterial physicochemical properties and their in vitro effects. Current methods lack the desired sensitivity, reliability, correlation and sophistication to provide more than limited, often equivocal, pieces of the overall nanomaterial performance parameter space, particularly in realistic physiological or environmental models containing cells, proteins and solutes. Therefore, improved physicochemical nanomaterial assays are needed to provide accurate exposure risk assessments and genuine predictions of in vivo behavior and therapeutic value. Simpler model nanomaterial systems in buffer do not accurately duplicate this complexity or predict in vivo behavior. A diverse portfolio of complementary material characterization tools and bioassays are required to validate nanomaterial properties in physiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Chemistry and Properties of Nanocrystals of Different Shapes
Burda, C., Chen, X., Narayanan, R., & El-Sayed, M. A. (2005) · Chemical Reviews · doi:10.1021/cr030063a · Cited by 7,230
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing
Tice, R. R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A., Kobayashi, H., Miyamae, Y., Rojas, E., Ryu, J.-C., & Sasaki, Y. F. (2000) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(2000)35:3<206::aid-em8>3.0.co;2-j · Cited by 4,860
Nanostructures in Biodiagnostics
Rosi, N. L., & Mirkin, C. A. (2005) · Chemical Reviews · doi:10.1021/cr030067f · Cited by 4,603
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Lewinski, N., Colvin, V., & Drezek, R. (2008) · Small · doi:10.1002/smll.200700595 · Cited by 2,810
Poland, C. A., Duffin, R., Kinloch, I., Maynard, A., Wallace, W. A. H., Seaton, A., Stone, V., Brown, S., MacNee, W., & Donaldson, K. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.111 · Cited by 2,645
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Cited by
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
Self-citationIversen, T.-G., Skotland, T., & Sandvig, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.02.003 · Cited by 1,239
Rampersad, S. N. (2012) · Sensors · doi:10.3390/s120912347 · Cited by 1,068
Qian, X., Zheng, Y., & Chen, Y. (2016) · Advanced Materials · doi:10.1002/adma.201602012 · Cited by 882
Two‐Dimensional Nanomaterials for Biomedical Applications: Emerging Trends and Future Prospects
Chimene, D., Alge, D. L., & Gaharwar, A. K. (2015) · Advanced Materials · doi:10.1002/adma.201502422 · Cited by 880
Wolinsky, J. B., Colson, Y. L., & Grinstaff, M. W. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.031 · Cited by 845
Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles
Walkey, C. D., Olsen, J. B., Song, F., Liu, R., Guo, H., Olsen, D. W. H., Cohen, Y., Emili, A., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn406018q · Cited by 815
Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity
Yu, T., Malugin, A., & Ghandehari, H. (2011) · ACS Nano · doi:10.1021/nn2013904 · Cited by 666
Shuhendler, A. J., Pu, K., Cui, L., Uetrecht, J. P., & Rao, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2838 · Cited by 623
Nanoparticles in Daily Life: Applications, Toxicity and Regulations
Gupta, R., & Xie, H. (2018) · Journal of Environmental Pathology, Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2018026009 · Cited by 553
George, S., Pokhrel, S., Xia, T., Gilbert, B., Ji, Z., Schowalter, M., Rosenauer, A., Damoiseaux, R., Bradley, K. A., Mädler, L., et al. (2010) · ACS Nano · doi:10.1021/nn901503q · Cited by 543
Extracellular matrix-based biomaterial scaffolds and the host response
Aamodt, J. M., & Grainger, D. W. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.003 · Cited by 509
Self-citationMagnetic nanoparticles: biomedical applications and challenges
Tran, N., & Webster, T. J. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm00994f · Cited by 459
Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Chang, M., Hou, Z., Wang, M., Li, C., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202004788 · Cited by 450
Development of in vitro systems for nanotoxicology: methodological considerations
Stone, V., Johnston, H., & Schins, R. P. F. (2009) · Critical Reviews in Toxicology · doi:10.1080/10408440903120975 · Cited by 427
Astashkina, A., Mann, B., & Grainger, D. W. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.001 · Cited by 424
Self-citationBiocompatibility of Mesoporous Silica Nanoparticles
Asefa, T., & Tao, Z. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300166u · Cited by 422
Cytokines as biomarkers of nanoparticle immunotoxicity
Elsabahy, M., & Wooley, K. L. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60064e · Cited by 407
Shear-Thinning Nanocomposite Hydrogels for the Treatment of Hemorrhage
Gaharwar, A. K., Avery, R. K., Assmann, A., Paul, A., McKinley, G. H., Khademhosseini, A., & Olsen, B. D. (2014) · ACS Nano · doi:10.1021/nn503719n · Cited by 403
Nanomaterials in food and agriculture: An overview on their safety concerns and regulatory issues
Jain, A., Ranjan, S., Dasgupta, N., & Ramalingam, C. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1160363 · Cited by 367
Therapeutic strategies to combat antibiotic resistance
Brooks, B. D., & Brooks, A. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.027 · Cited by 367
Health and Ecosystem Risks of Graphene
Hu, X., & Zhou, Q. (2013) · Chemical Reviews · doi:10.1021/cr300045n · Cited by 360
Gas‐Generating Nanoplatforms: Material Chemistry, Multifunctionality, and Gas Therapy
Yu, L., Hu, P., & Chen, Y. (2018) · Advanced Materials · doi:10.1002/adma.201801964 · Cited by 360
Experimental Considerations on The Cytotoxicity of Nanoparticles
Kong, B., Seog, J. H., Graham, L. M., & Lee, S. B. (2011) · Nanomedicine · doi:10.2217/nnm.11.77 · Cited by 357
Effect of Nanoparticles on the Cell Life Cycle
Mahmoudi, M., Azadmanesh, K., Shokrgozar, M. A., Journeay, W. S., & Laurent, S. (2011) · Chemical Reviews · doi:10.1021/cr1003166 · Cited by 352
Upconverting and NIR emitting rare earth based nanostructures for NIR-bioimaging
Hemmer, E., Venkatachalam, N., Hyodo, H., Hattori, A., Ebina, Y., Kishimoto, H., & Soga, K. (2013) · Nanoscale · doi:10.1039/c3nr02286b · Cited by 343
Nanoparticle interactions with co-existing contaminants: joint toxicity, bioaccumulation and risk
Deng, R., Lin, D., Zhu, L., Majumdar, S., White, J. C., Gardea-Torresdey, J. L., & Xing, B. (2017) · Nanotoxicology · doi:10.1080/17435390.2017.1343404 · Cited by 329
The Gold Standard: Gold Nanoparticle Libraries To Understand the Nano–Bio Interface
Alkilany, A. M., Lohse, S. E., & Murphy, C. J. (2013) · Accounts of Chemical Research · doi:10.1021/ar300015b · Cited by 324
The toxicity of nanoparticles and their interaction with cells: an in vitro metabolomic perspective
Awashra, M., & Młynarz, P. (2023) · Nanoscale Advances · doi:10.1039/d2na00534d · Cited by 319
Paur, H.-R., Cassee, F. R., Teeguarden, J., Fissan, H., Diabate, S., Aufderheide, M., Kreyling, W. G., Hänninen, O., Kasper, G., Riediker, M., et al. (2011) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2011.06.005 · Cited by 316
Biocompatibility of Mesoporous Silica Nanoparticles?
Shi, Y., Miller, M. L., & Di Pasqua, A. J. (2016) · Comments on Inorganic Chemistry · doi:10.1080/02603594.2015.1088439 · Cited by 315
Rivera Gil, P., Oberdörster, G., Elder, A., Puntes, V., & Parak, W. J. (2010) · ACS Nano · doi:10.1021/nn1025687 · Cited by 314
Buya, A. B., Beloqui, A., Memvanga, P. B., & Préat, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121194 · Cited by 301
Nanophotosensitizers toward advanced photodynamic therapy of Cancer
Lim, C.-K., Heo, J., Shin, S., Jeong, K., Seo, Y. H., Jang, W.-D., Park, C. R., Park, S. Y., Kim, S., & Kwon, I. C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.09.012 · Cited by 293
Dou, Y., Guo, Y., Li, X., Li, X., Wang, S., Wang, L., Lv, G., Zhang, X., Wang, H., Gong, X., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07473 · Cited by 288
Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety
Wilkinson, L. J., White, R. J., & Chipman, J. K. (2011) · Journal of Wound Care · doi:10.12968/jowc.2011.20.11.543 · Cited by 280
Saidin, S., Jumat, M. A., Mohd Amin, N. A. A., & Saleh Al-Hammadi, A. S. (2021) · Materials Science and Engineering: C · doi:10.1016/j.msec.2020.111382 · Cited by 279
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
Severino, P., Andreani, T., Macedo, A. S., Fangueiro, J. F., Santana, M. H. A., Silva, A. M., & Souto, E. B. (2012) · Journal of Drug Delivery · doi:10.1155/2012/750891 · Cited by 276
ZnO nanomaterials: Green synthesis, toxicity evaluation and new insights in biomedical applications
Verma, R., Pathak, S., Srivastava, A. K., Prawer, S., & Tomljenovic-Hanic, S. (2021) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2021.160175 · Cited by 272
Health impact and safety of engineered nanomaterials
Teow, Y., Asharani, P. V., Hande, M. P., & Valiyaveettil, S. (2011) · Chemical Communications · doi:10.1039/c0cc05271j · Cited by 269
Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities
Agrahari, V., & Agrahari, V. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.047 · Cited by 253
Nanocosmetics and Nanomedicines
(2011) · doi:10.1007/978-3-642-19792-5 · Cited by 116
Lee, S., Choi, J., Shin, S., Im, Y.-M., Song, J., Kang, S. S., Nam, T.-H., Webster, T. J., Kim, S.-H., & Khang, D. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.01.006 · Cited by 108
Topical, aqueous, clear cyclosporine formulation design for anterior and posterior ocular delivery
Cholkar, K., Gilger, B. C., & Mitra, A. K. (2015) · Translational Vision Science & Technology · doi:10.1167/tvst.4.3.1 · Cited by 103
Endotoxin Contamination in Nanomaterials Leads to the Misinterpretation of Immunosafety Results
Li, Y., Fujita, M., & Boraschi, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00472 · Cited by 99
Gupta, V., & Trivedi, P. (2018) · Lipid Nanocarriers for Drug Targeting · doi:10.1016/b978-0-12-813687-4.00015-3 · Cited by 96
Di Tommaso, C., Torriglia, A., Furrer, P., Behar-Cohen, F., Gurny, R., & Möller, M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.004 · Cited by 84
Alternative in vitro assays in nanomaterial toxicology
Hartung, T., & Sabbioni, E. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.153 · Cited by 84
Toxicity and regulations of food nanomaterials
Ranjan, S., Dasgupta, N., Singh, S., & Gandhi, M. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-018-00851-z · Cited by 62
Vadlapudi, A. D., Cholkar, K., Vadlapatla, R. K., & Mitra, A. K. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0157 · Cited by 62
Metadata
- Authors
- Jones, C. F., & Grainger, D. W.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 61
- Issue
- 6
- Pages
- 438-456
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1984044241
- Cited by
- 554
- References
- 153
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.